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Appendix!I.!Tables*2*and*3.* **
Table!2.*Protein*quantification*and*imageJ*qualitative*analysis*lysate*followed*by*partialSpurification*using*ion*exchange*chromatography,*precipitation*of*QFT*with*30%*(NH4)2SO4*and*elution*profile*peak*fractions*of*resolubilized*precipitate*by*ion*exchange*chromatography.*** Sample* Total*Protein* %*BPV1*L1* Total*BPV1*L1*WCL* 366.0*mg* 9.13%* 33.42*mg*S1* 108.0*mg* 3.51%* 3.78*mg*P1* 256.0*mg* 11.58%* 29.64*mg*QFT* 102.0*mg* 1.5%* 1.53*mg*WFT* 10.6*mg* NA* NA*30%*AS*S* 90.6*mg* NA* NA*30%*AS*P* 22.0*mg* 5.03%* 1.11*mg*F16* 0.08*mg* 9.19%* 0.01*mg*F18* 0.09*mg* 1.92%* 0.002*mg***
Table!3.*Protein*concentration*quantification*and*imagej*analysis*of*variable*amounts*of**(NH4)2SO4.** Sample* Total*Protein* %*BPV1*L1* Total*BPV1*L1*BP*QFT* 1.78* 1.5%* 0.03*mg*20%*AS*P* 0.71* 15.5%* 0.11*mg*25%*AS*P* 0.86* 21.5%* 0.18*mg*30%*AS*P* 1.06* 19.05%* 0.20*mg*35%*AS*P* 1.08* NA* NA**
!
!
!
!
!
!
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Appendix!II.!Elution*profile*of*analyte*solution*containing*BPV1*L1*protein!in*ion*exchange*chromatography*using*a*NaCl*gradient.****
**** *
* 24*
Appendix!III.*Elution*profile*of*size*exclusion*chromatography*of*BPV1*L1*protein*concentrate*sample;*compared*to*elution*profile*of*protein*standards*(data*not*shown)*confirming*BPV1*L1*protein*had*formed*capsomereScomplexes.***
******** *
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Appendix!IV.*Coomassie*stained*gel*of*variable*amounts*of*(NH4)2SO4*precipitation*of*BPV1*L1*protein.**
****** **
